ArticleJournal of medical biochemistry2025
Effect of magnesium sulfate and personalised dietary guidance on hemodynamics and inflammatory cytokines in pregnancy-induced hypertension.
Article in Journal of medical biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pregnancy-induced hypertension (PIH) is a significant cause of maternal and neonatal complications, often linked to vascular dysfunction and inflammatory responses. This study aimed to evaluate the effects of magnesium sulfate (MS) combined with personalised dietary guidance on hemodynamic parameters and inflammatory cytokine profiles in PIH patients. Methods: A total of 108 PIH patients were randomly assigned to two groups: a research group (MS and dietary guidance) and a control group (dietary guidance only). Hemodynamic parameters, including systolic and diastolic blood pressure (SBP, DBP), plasma viscosity (PV), and erythrocyte aggregation index (EI), were measured, along with inflammatory cytokines [Interleukin-6 (IL-6), Interleukin-10 (IL-10), and Interleukin-1b (IL-1b)], before and after treatment. Results: The research group, which received both MS and dietary guidance, showed significant reductions in SBP, DBP, PV, and EI compared to the control group. Additionally, inflammatory cytokines IL-6 and IL-1b were significantly reduced in the research group, indicating an improvement in the inflammatory response. While IL-10 levels decreased in both groups, this change was not statistically significant. Conclusions: Combining magnesium sulfate and personalised dietary guidance effectively improves hemodynamic stability and reduces inflammatory markers in PIH patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.